Skip to main content

Cetek Raises $10M in VC Financing

NEW YORK, Jan. 5 (GenomeWeb News) - Cetek raised $10 million from investors to advance its drug-discovery platform, the company said earlier this week.

 

Participating investors include Argonaut Private Equity, Ventry Industries, Gainesborough Investments, James L. Waters, and Stata Ventures. They are all current Cetek investors.

 

Cetek approaches drug discovery using high throughput capillary electrophoresis screening technology and chemical biology-focused drug source. The company said it uses its technologies through service agreements and collaborations.

 

The Marlborough, Mass-based company also announced a scientific advisory board. The chairman of the board is Cetek founder Barry L. Karger. Other members include K. Frank Austen from Harvard Medical School, James D. Griffin from Harvard Medical School, Charles L. Cooney, from the MIT Program on the Pharmaceutical Industry, and Martin S. Hirsch from Harvard School of Public Health; and Infectious Disease Service at the Massachusetts General Hospital.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.